Proxeon and Varian Announce OEM Agreement
News Apr 29, 2008
Proxeon has announced that the company has entered into an OEM agreement with Varian Inc. under which Proxeon’s nanoscale liquid chromatography system (EASY-nLC™) will be available to interface with Varian’s 920-MS Triple Quadrupole Fourier Transform Mass Spectrometer (TQ-FTMS). Under the non-exclusive, worldwide agreement, the nano-LC system will be marketed and sold as the Varian 216-LC.
Marten Winge, CEO at Proxeon, stated: "The performance of LC-MS configurations has become increasingly significant in the proteomics market. This fully integrated, split-free nanoscale LC system has been designed and optimized for use with MS and, in particular, the type of LC-MS applications used in proteomics. We are delighted that Varian, a well-established company with an excellent reputation in the world of HPLC and mass spectrometry, has selected our system for interfacing with their MS instrument. Their choice further confirms the performance and quality of Proxeon products and gives even more researchers the chance to work with our state-of-the-art systems."
Mr. Winge continued, "Varian is the second major MS instrument supplier to have selected the Easy-nLC system as the preferred LC solution for its customers. Since the system is already used in many prestigious proteomics laboratories and will continuing to be sold through other MS vendors and our own sales team, we are extremely optimistic about the increasing success of this product during 2008."
No financial terms of the agreement are disclosed.
Comet "Chury's" Late BirthNews
Comets which consist of two parts, like Chury, can form after a catastrophic collision of larger bodies. Such collisions may have taken place in a later phase of our solar system, which suggests that Chury can be much younger than previously assumed. This is shown through computer simulations.READ MORE
Nanotechnology Detects Molecular Biomarker for OsteoarthritisNews
For the first time, scientists have been able to measure a specific molecule indicative of osteoarthritis and a number of other inflammatory diseases using a newly developed technology. This preclinical study used a solid-state nanopore sensor as a tool for the analysis of hyaluronic acid.READ MORE
Comments | 0 ADD COMMENT
10th International Conference on Mass Spectrometry and Chromatography
Oct 08 - Oct 09, 2018